Related Experiment Videos
Problems in assessment of acute melatonin overdose
1Southern Poison Center, University of Tennessee, Memphis, USA.
Southern Medical Journal
|April 1, 1997
Summary
Melatonin, a popular sleep aid, can cause disorientation and lethargy in overdose. This case highlights that melatonin is pharmacologically active and not a benign substance, even as a supplement.
Area of Science:
- Pharmacology
- Toxicology
- Neuroscience
Background:
- Melatonin is widely available as a dietary supplement in the U.S., marketed for sleep, stress, jet lag, and aging.
- Acute melatonin poisoning cases are rare, potentially due to challenges in toxicity assessment.
- Melatonin's pharmacological activity and potential interactions are not fully understood by the public.
Observation:
- A 66-year-old male experienced lethargy and disorientation after ingesting 24 mg of melatonin before prostate surgery.
- The patient recovered fully post-ingestion and surgery.
Findings:
- Melatonin, despite not being a regulated drug, exhibits pharmacological activity.
- Potential interactions exist with benzodiazepines, naloxone, flumazenil, and endogenous melatonin receptors.
Implications:
- Melatonin should not be considered a harmless substance, especially in overdose scenarios.
- Further research is warranted to fully understand melatonin's toxicity profile and drug interactions.